Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 

A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required. 

In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21. 

Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies. 

Casana, the company behind the Heart Seat, is now pursuing approvals for additional indications. 

The two new leadless pacemakers, the Micra AV2 and Micra VR2, feature much longer batteries than previous models. 

The accusations pertain to the Amsterdam-based corporation’s sales of diagnostic imaging equipment in China, the SEC announced May 11. 

New data suggest that the burden of atherosclerosis on imaging might not be as indicative of major cardiovascular events as a person’s age and sex.